New Player on an old field; the Keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome

Dionysios V. Chartoumpekis, Thomas W Kensler

Research output: Contribution to journalArticle

Abstract

Nuclear erythroid factor 2 like 2 (Nrf2) has been described as a transcription factor that serves as a master regulator of the adaptive response to exogenous and endogenous oxidative and electrophilic stresses. Evidence of Nrf2 crosstalk with other molecular pathways is increasing; recent publications have proposed a role of Nrf2 in the development of obesity and in the highly regulated process of adipocyte differentiation through its interaction with other transcription factors and receptors implicated in metabolic regulation. In the present review, we discuss the available data on the possible role of Nrf2 in obesity and metabolic syndrome and the feasibility of using Nrf2 as a therapeutic target in the clinical setting.

Original languageEnglish (US)
Pages (from-to)137-145
Number of pages9
JournalCurrent Diabetes Reviews
Volume9
Issue number2
StatePublished - 2013
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Transcription Factors
Obesity
Adipocytes
Oxidative Stress
Therapeutics

Keywords

  • Diabetes
  • Keap1
  • Metabolism
  • Nrf2
  • Obesity
  • Oxidative stress

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

New Player on an old field; the Keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome. / Chartoumpekis, Dionysios V.; Kensler, Thomas W.

In: Current Diabetes Reviews, Vol. 9, No. 2, 2013, p. 137-145.

Research output: Contribution to journalArticle

@article{b47789b1a1544fdfb79e9150304fe42c,
title = "New Player on an old field; the Keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome",
abstract = "Nuclear erythroid factor 2 like 2 (Nrf2) has been described as a transcription factor that serves as a master regulator of the adaptive response to exogenous and endogenous oxidative and electrophilic stresses. Evidence of Nrf2 crosstalk with other molecular pathways is increasing; recent publications have proposed a role of Nrf2 in the development of obesity and in the highly regulated process of adipocyte differentiation through its interaction with other transcription factors and receptors implicated in metabolic regulation. In the present review, we discuss the available data on the possible role of Nrf2 in obesity and metabolic syndrome and the feasibility of using Nrf2 as a therapeutic target in the clinical setting.",
keywords = "Diabetes, Keap1, Metabolism, Nrf2, Obesity, Oxidative stress",
author = "Chartoumpekis, {Dionysios V.} and Kensler, {Thomas W}",
year = "2013",
language = "English (US)",
volume = "9",
pages = "137--145",
journal = "Current Diabetes Reviews",
issn = "1573-3998",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - New Player on an old field; the Keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome

AU - Chartoumpekis, Dionysios V.

AU - Kensler, Thomas W

PY - 2013

Y1 - 2013

N2 - Nuclear erythroid factor 2 like 2 (Nrf2) has been described as a transcription factor that serves as a master regulator of the adaptive response to exogenous and endogenous oxidative and electrophilic stresses. Evidence of Nrf2 crosstalk with other molecular pathways is increasing; recent publications have proposed a role of Nrf2 in the development of obesity and in the highly regulated process of adipocyte differentiation through its interaction with other transcription factors and receptors implicated in metabolic regulation. In the present review, we discuss the available data on the possible role of Nrf2 in obesity and metabolic syndrome and the feasibility of using Nrf2 as a therapeutic target in the clinical setting.

AB - Nuclear erythroid factor 2 like 2 (Nrf2) has been described as a transcription factor that serves as a master regulator of the adaptive response to exogenous and endogenous oxidative and electrophilic stresses. Evidence of Nrf2 crosstalk with other molecular pathways is increasing; recent publications have proposed a role of Nrf2 in the development of obesity and in the highly regulated process of adipocyte differentiation through its interaction with other transcription factors and receptors implicated in metabolic regulation. In the present review, we discuss the available data on the possible role of Nrf2 in obesity and metabolic syndrome and the feasibility of using Nrf2 as a therapeutic target in the clinical setting.

KW - Diabetes

KW - Keap1

KW - Metabolism

KW - Nrf2

KW - Obesity

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84877809314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877809314&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 137

EP - 145

JO - Current Diabetes Reviews

JF - Current Diabetes Reviews

SN - 1573-3998

IS - 2

ER -